Get notified when GWLL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Restatement (new) — The company is restating its prior quarterly financial statements, which is a material event for investors.
  • Material Weakness (new) — The company restated prior financial statements due to a material error in recording legal fees, indicating a control deficiency.
  • Going Concern (worsened) — The going concern language is unchanged, but the restated financials show a working capital deficit of $(277,693) versus a positive $190,055 previously, indicating a materially weaker liquidity position.
OTC: GWLL GOLDENWELL BIOTECH, INC. 10-Q/A

revenue $0, net income -$38,536. Goldenwell Biotech restates Q1 2025: wider loss, negative working capital, going concern

Filed June 26, 2026 · Period ending March 31, 2025 · Compared to 10-Q May 27, 2025 · ~1 min read

Key Financials

SEC XBRL

Period financials are unchanged from the original 10-Q (same period end Mar 31, 2025). This amendment updates disclosure only — see the diff below.

Key Changes

  • high

    Restated Q1 2025 net loss widens to $38,536 from $34,377, driven by a $4,160 legal fee accrual.

    MD&A: Net loss verify on EDGAR →
  • high

    Working capital swings from positive $190,055 to a deficit of $(277,693) due to $275,833 of accrued legal fees.

    MD&A: Working capital verify on EDGAR →
  • high

    Company discloses its prior 10-Q could no longer be relied upon and fully restates the quarter.

    Explanatory Note verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (CRWD 10-Q) is open in full — no account needed.

Partner

Trade GWLL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify